Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
(Infant outcomes) Any supplements containing iron showed no clear difference in preterm birth (less than 37 weeks of gestation) (ALL) compared with same supplements without iron or no treatment/placebo (no iron or… (moderate certainty).
(Infant outcomes) Any supplements containing iron showed no clear difference in neonatal death (within 28 days after delivery) (ALL) compared with same supplements without iron or no treatment/placebo (no iron or… (low certainty).
(Infant outcomes) Any supplements containing iron showed no clear difference in congenital anomalies (ALL) compared with same supplements without iron or no treatment/placebo (no iron or… (low certainty).
(Maternal outcomes) Any supplements containing iron may leads to lower maternal anaemia at term (Hb less than 110 g/L at 37 weeks'… compared with same supplements without iron or no treatment/placebo (no iron or… (low certainty).
(Maternal outcomes) Any supplements containing iron may leads to lower maternal iron deficiency at term (as defined by as defined by… compared with same supplements without iron or no treatment/placebo (no iron or… (low certainty).
It is very uncertain whether (Maternal outcomes) Any supplements containing iron changes maternal death (death while pregnant or within 42 days of… compared with same supplements without iron or no treatment/placebo (no iron or… (very low certainty).
It is very uncertain whether (Maternal outcomes) Any supplements containing iron changes side effects (any reported throughout the intervention period) (ALL) compared with same supplements without iron or no treatment/placebo (no iron or… (very low certainty).
The intervention leads to higher at least 50% of maximum pain relief over 4 to 6 hours (high certainty).
The intervention leads to lower participants remedicating within 8 hours (high certainty).
The intervention showed no clear difference in participants with at least 1 adverse event (all diclofenac potassium… (moderate certainty).
Budesonide MMX® 9 mg probably leads to higher remission (combined clinical and endoscopic remission) compared with placebo (moderate certainty).
Budesonide MMX® 6 mg showed no clear difference in endoscopic improvement compared with placebo (moderate certainty).
Budesonide MMX® 6 mg showed no clear difference in histologic remission compared with placebo (low certainty).
Budesonide MMX® 6 mg showed no clear difference in serious adverse events compared with placebo (low certainty).
It is very uncertain whether budesonide MMX® 6 mg changes adverse events compared with placebo (very low certainty).
Budesonide MMX® 6 mg showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
Budesonide 10 mg showed no clear difference in endoscopic improvement compared with prednisolone 40 mg (low certainty).
It is very uncertain whether budesonide 10 mg changes endoscopic remission compared with prednisolone 40 mg (very low certainty).
It is very uncertain whether budesonide 10 mg changes histologic remission compared with prednisolone 40 mg (very low certainty).